On November 20, 2024, Julie Sullivan of Greenberg Traurig, LLP and Dr. Razmi, Managing Director of Zoi Capital, had an hour-long discussion about the opportunities and perils of AI for health and in healthcare delivery and medical research. They delved into the key topics that will make or break the adoption of this very promising technology into a sector that badly needs help in achieving its mission. Opus Connect facilitated this long-form discussion that allowed Julie and Ron to go deep into the key drivers and barriers.
Careful analysis of the potential ROI of the technology for the intended use case, seamless fit with existing workflows, and ensuring real-world availability of the needed data are just a starting place for deciding if you should spend years building and commercializing a health AI solution. More analysis upfront can save you years of frustration!
This was part of a day-long session that covered many aspects of healthcare in private markets.
